Einstein Francisco Camargos, Claudia Kimie Suemoto, & Paulo Caramelli. (2024). Monoclonal antibodies for Alzheimer disease: Statistical significance vs clinical efficacy. Brazilian Society of Geriatrics and Gerontology.
Чикаго-гийн эшлэл (17 дахь хэвлэлт)Einstein Francisco Camargos, Claudia Kimie Suemoto, ба Paulo Caramelli. Monoclonal Antibodies for Alzheimer Disease: Statistical Significance Vs Clinical Efficacy. Brazilian Society of Geriatrics and Gerontology, 2024.
MLA -ийн эшлэл (9 дэх хэвлэлт)Einstein Francisco Camargos, et al. Monoclonal Antibodies for Alzheimer Disease: Statistical Significance Vs Clinical Efficacy. Brazilian Society of Geriatrics and Gerontology, 2024.
Анхааруулга: Эдгээр ишлэлүүд үргэлж 100% үнэн зөв биш байж магадгүй.